Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

Good sleep is essential for brain health. During sleep and rest, the glymphatic system, the brain's waste-clearing process, ...

Philips (NYSE:PHG) continues to find ways to advance patient care, whether in a hospital or at home, or somewhere in between.

The National Science Foundation has begun dismantling a major ocean monitoring network more than a decade earlier than planned. Some scientists say it will be a “tragic” loss of crucial information ...

NEW ORLEANS — Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with ...

June 6 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform ...

Remote patient monitoring was supposed to make healthcare easier. Patients with chronic illnesses could stay home while devices quietly tracked blood pressure, glucose levels, oxygen saturation and ...

BALTIMORE--(BUSINESS WIRE)--Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with Stanford Health Care to support the clinical ...

Patient collections are playing a bigger and bigger role in health systems’ total revenues, bringing a new focus on the difficulties organizations face in securing timely, or any, payments for their ...

Many small firms and sole practitioners are unclear about how exactly to fulfill the monitoring and remediation requirements in Statement on Quality Management Standards (SQMS) No. 1, A Firm’s System ...

The recent Food and Drug Administration (FDA) rejection of RP1, an experimental immunotherapy for advanced melanoma, has sparked frustration among oncologists and patients who see it as another ...